Regulacje i polityka gospodarcza · 28/08/2017

U.S. Customs and Border Protection Issues Final Determinations on Country of Origin for Pharmaceutical Products

U.S. Customs and Border Protection has issued final determinations on the country of origin for six pharmaceutical products, including meloxicam tablets from Italy, bimatoprost ophthalmic solution from Taiwan, and niacin ER tablets from Belgium or Switzerland, affecting U.S. Government procurement.